CompaniesNeuTec Pharma

NeuTec Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

266

By Phase

PHASE3: 2PHASE1/PHASE2: 1

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details

Recent Trials

NCT04646109Collaborator
Ivermectin for Severe COVID-19 Management
PHASE3Completed
66 participants
Started: May 11, 2020 · Completed: Sep 2, 2020
NCT00217815Lead Sponsor
Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer
PHASE1/PHASE2Completed
20 participants
Started: Sep 30, 2005 · Completed: Oct 31, 2006
NCT00217841Lead Sponsor
Aurograb and Vancomycin in MRSA Infection
PHASE3Completed
180 participants
Started: Jan 31, 2004 · Completed: Mar 31, 2006